Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
Recruiting · NCT04195347 · Registry updated 2026-06-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase | Digestive System Diseases, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, acute pancreatitis, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm, pancreas disorder, pancreatitis | Recruiting | Phase 1 / Phase 2 | 2026-06-03 | NCT04195347 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CalciMedica, Inc. | 1 |
| St. Jude Children's Research Hospital | 169 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cincinnati Children's Hospital Medical Center | Cincinnati | United States | 1 |
| Novant Health Presbyterian Hemby Children's Hospital | Charlotte | United States | 4 |
| St. Jude Children's Research Hospital | Memphis | United States | 194 |